Tri-sprintec and Nail abnormalities - a phase IV clinical study of FDA data

Summary:

We study 3,774 people who take Tri-sprintec (ethinyl estradiol; norgestimate) or have Nail abnormalities. No report of Nail abnormalities is found in people who take Tri-sprintec.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Tri-sprintec?

Tri-sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 1,428 Tri-sprintec users. Check the latest studies of Tri-sprintec.

What is Nail Abnormalities?

Nail abnormalities (abnormal nail) is found to be associated with 242 drugs and 636 conditions by eHealthMe. Check the latest studies of Nail abnormalities.

On Oct, 12, 2025

No report is found.

Do you take Tri-sprintec and have Nail abnormalities?

- Check whether Nail abnormalities is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tri-sprintec:

Tri-sprintec (1,428 reports)

Nail abnormalities treatments and more:

Nail abnormalities (2,346 reports)

How severe was Nail abnormalities and when was it recovered:

Nail abnormalities in Tri-sprintec

Expand to all the drugs that have ingredients of ethinyl estradiol; norgestimate:

Nail abnormalities and drugs with ingredients of ethinyl estradiol; norgestimate (2 reports)

Browse all side effects of Tri-sprintec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nail abnormalities:

Nail abnormalities

Browse all the conditions that are associated with Nail abnormalities:

Nail abnormalities

Drugs similar to Tri-sprintec and Nail abnormalities :

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestimate (the active ingredients of Tri-sprintec) and Tri-sprintec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.